Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CPHI stock hub

China Pharma Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CPHIis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
21.5M
NYSEAMERICAN
Market data

Live price

Current market quote for this ticker.

Current price
CPHI
In the news

Latest news · CPHI

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-20.9
P25 -105.6P50 -46.5P75 -3.1
ROIC-10.1
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CPHI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
202
Groups with data
11
Currency
USD
Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001106644
Company name
China Pharma Holdings, Inc.
Country
China
Country code
US
Cusip
16941T104
Employees
215
Employees Change
-9%
Employees Change Percent
-4.02
Enterprise value
$25M
Exchange
NYSEAMERICAN
Financial currency
USD
First seen
2026-05-09
Industry
Drug Manufacturers - Specialty & Generic
Isin
US16941T4013
Last refreshed
2026-05-10
Market cap
$21.5M
Market cap category
Nano-Cap
Price
$0.53
Price currency
USD
Rev Per Employee
19,275.67x
Sector
Healthcare
Sic
2834
Symbol
CPHI
Website
https://www.chinapharmaholdings.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-14.84%
EV/FCF
281.31x
EV/Sales
6.04x
FCF yield
0.41%
P/B ratio
0.36x
P/S ratio
5.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
-74.5%
EBITDA Margin
-38.22%
FCF margin
2.15%
Gross margin
-3.18%
Gross Profit
$-131,950
Net Income
$-3.2M
Net Income Growth Quarters
5%
Net Income Growth Years
1%
Pretax Margin
-76.91%
Profit Margin
-76.91%
Profit Per Employee
$-14,826
ROA
-8.41
Roa5y
-11.18
ROCE
-13.08
ROE
-20.91
Roe5y
-52.24
ROIC
-10.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
-41.86%
Cagr15y
-40.36%
Cagr1y
-71.68%
Cagr20y
-29.49%
Cagr3y
-68.7%
Cagr5y
-72.23%
EPS Growth Quarters
4
EPS Growth Years
3
FCF Growth Q
-45.73%
OCF Growth Q
-49.13%
OCF Growth10 Y
-26.79%
Revenue Growth
-8.49x
Revenue Growth Q
8.11x
Revenue Growth Quarters
1x
Revenue Growth Years
0x
Revenue Growth3 Y
-20.03x
Revenue Growth5 Y
-17.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
$0.18
Assets
$31M
Cash
$345,112
Current Assets
$2.3M
Current Liabilities
$7.4M
Debt
$3.9M
Debt Equity
$0.17
Debt FCF
$43.71
Equity
$22.7M
Interest Coverage
-30.26
Liabilities
$8.3M
Long Term Assets
$28.7M
Long Term Liabilities
$859,353
Net Cash
$-3.5M
Net Cash By Market Cap
$-16.49
Net Debt Equity
$0.16
Net Debt FCF
$39.83
Tangible Book Value
$-1.3M
Tangible Book Value Per Share
$-0.09
WACC
8.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.32
Inventory Turnover
2.19
Net Working Capital
$-1.6M
Quick ratio
0.09
Working Capital
$-5.1M
Working Capital Turnover
$-1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-145.73%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-99.56%
1Y total return
-71.66%
200-day SMA
1.27
3Y total return
-96.94%
50-day SMA
0.6
50-day SMA vs 200-day SMA
50under200
5Y total return
-99.83%
All Time High
2,602.5
All Time High Change
-99.98%
All Time High Date
2003-10-28
All Time Low
0.5
All Time Low Change
6%
All Time Low Date
2026-05-01
ATR
0.05
Beta
1
Beta1y
0.46
Beta2y
0.57
Ch YTD
-56.2
High
0.57
High52
2.6
High52 Date
2025-05-22
High52ch
-79.6%
Low
0.52
Low52
0.5
Low52 Date
2026-05-01
Low52ch
6%
Ma50ch
-11.56%
Price vs 200-day SMA
-58.2%
RSI
38.79
RSI Monthly
29.1
RSI Weekly
28.47
Sharpe ratio
-1.29x
Sortino ratio
-1.63
Total Return
-145.73%
Tr YTD
-56.2
Tr15y
-99.96%
Tr1m
-16.54%
Tr1w
0.51%
Tr3m
-23.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
$-3.1M
Operating margin
-74.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
37,840,614%
Float Percent
93.38%
Net Borrowing
-294,027
Shares Insiders
6.62%
Shares Institutions
0.07%
Shares Out
40,522,002
Shares Qo Q
74.52%
Shares Yo Y
145.73%
Short Float
0.02%
Short Ratio
0.27
Short Shares
0.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$88,937
Average Volume
23,674.1x
Bv Per Share
1.47
CAPEX
$-59,324
Ch10y
-99.56
Ch15y
-99.96
Ch1m
-16.54
Ch1w
0.51
Ch1y
-71.66
Ch20y
-99.91
Ch3m
-23.62
Ch3y
-96.94
Ch5y
-99.83
Ch6m
-65.81
Change
0.74%
Change From Open
-7
Close
0.53
Days Gap
8.33
Depreciation Amortization
1,503,635
Dollar Volume
3,488.4
Earnings Date
2026-05-11
Earnings Time
amc
EBIT
$-3.1M
EBITDA
$-1.6M
EPS
$-0.74
F Score
3
FCF
$88,937
FCF EV Yield
0.36x
FCF Per Share
$0
Financing CF
-294,027
Fiscal Year End
December
Investing CF
-137,251
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-04-01
Last Report Date
2025-12-31
Last Split Date
2025-04-15
Last Split Type
Reverse
Last10k Filing Date
2026-04-01
Ma150
1.13
Ma150ch
-53.18%
Ma20
0.59
Ma20ch
-10.56%
Net CF
-281,767
Next Earnings Date
2026-05-22
Open
0.57
Optionable
No
P FCF Ratio
241.5
P OCF Ratio
144.9
Position In Range
25.42
Ppne
4,573,792
Price Date
2026-05-08
Relative Volume
0.28x
Revenue
4,144,268x
Tr20y
-99.91%
Tr6m
-65.81%
Volume
6,581.9
Z Score
-2.1
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CPHI pay a dividend?

Capital-return profile for this ticker.

Performance

CPHI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-71.7%
S&P 500 1Y: n/a
3Y total return
-96.9%
S&P 500 3Y: n/a
5Y total return
-99.8%
S&P 500 5Y: n/a
10Y total return
-99.6%
S&P 500 10Y: n/a
Ownership

Who owns CPHI?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.1%
Float: +93.4% of shares outstanding
Insider ownership
+6.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+0.0%
0.3 days to cover
Y/Y dilution
+145.7%
Negative means the company is buying back shares.
Technical

CPHI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.8
Neutral momentum band
Price vs 200-day MA
-58.2%
50/200-day relationship not available
Beta (5Y)
1.00
Moves roughly with the market
Sharpe ratio
-1.29
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CPHI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CPHI stock rating?

China Pharma Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CPHI analysis?

The full report lives at /stocks/CPHI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CPHI?

The latest report frames CPHI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CPHI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.